Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Uveal Melanoma 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

Radiosurgery 4Paclitaxel 4atezolizumab 3Nivolumab 3selpercatinib 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Irinotecan 2Carboplatin 2vandetanib 1taxane 1sargramostim 1romidepsin 1repotrectinib 1pralsetinib 1pentetreotide 1niraparib 1liposomal doxorubicin 1dostarlimab 1aldesleukin 1Vinorelbine 1Topotecan 1Thalidomide 1Temozolomide 1Specimen Handling 1Rose Bengal 1Radiation 1RRx-001 1Quality of Life 1Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Rose Bengal × Endocrine × Clear all
NCT00986661 2022-11-02

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Provectus Pharmaceuticals

Phase 1 Unknown
78 enrolled
BreastDermatologicEndocrineGastrointestinalThoracic

Uveal Melanoma, Breast Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡